Daiichi Sankyo to buy 51% in Ranbaxy

in Company & Markets

Japan’s second-largest pharmaceutical company Daiichi Sankyo buys up to 51 per cent stake in Indian Ranbaxy Laboratories at Rs 737 a share.

Like ThePicky, follow us on Twitter, or get daily updates via email.

Related entries:

Leave a Comment